MARTINSRIED, Germany, March 26, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (Prime Standard Segment) announced today that its current board member Professor Andreas Pluckthun intends to resign from the Supervisory Board with effect of 16 May, 2007. Professor Pluckthun is leaving the board at his own request, in order to devote additional time to his increasing number of academic research programs at the University of Zurich, as well as to be able to pursue other entrepreneurial opportunities. The Supervisory Board accepted Prof. Pluckthun's decision with regret and thanked him for his long-lasting support and his contribution to the growth and success of the Company. As successor to Professor Pluckthun, the Supervisory Board will propose the nomination of Dr. Walter Blattler, formerly Executive Vice President, Science and Technology of ImmunoGen, Inc., at the Company's next annual shareholder meeting in May. Professor Pluckthun will remain connected to MorphoSys as an advisor on future technology development.
